减少骨髓细胞的结合,并增加干细胞衍生的HPS2中性粒细胞的巨细胞的吸收
Steven Ds Webbers1,2, Cathelijn Em Aarts3, Bart Klein3
1Department of Molecular Hematology, Sanquin Research, Amsterdam University Medical Center (AUMC), University of Amsterdam, Amsterdam, Netherlands S.webbers@sanquin.nl.
Life science alliance
|January 18, 2024
概括
赫曼斯基-普德拉克综合征2型 (HPS2) 损害了患者衍生的干细胞中性粒细胞的发育. 巨细胞清除发育中的中性粒细胞,在这种罕见的遗传疾病中限制它们的数量.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学是一种遗传学.
- 细胞生物学 细胞生物学
背景情况:
- 赫曼斯基-普德拉克综合征2型 (HPS2) 是一种罕见的自体逆向性疾病,由AP3B1基因突变引起.
- HPS2导致蛋白质错误分类和严重的中性质 (中性粒细胞数量低).
- 现有的动物模型不能完全复制HPS2的人类临床特征.
研究的目的:
- 通过来自HPS2患者的诱导多能干细胞 (iPSCs) 调查颗粒形成 (中性粒细胞的发展).
- 了解HPS2中中性质衰竭背后的细胞机制.
- 为研究HPS2病理生理学建立人类iPSC模型.
主要方法:
- 从一个HPS2患者生成iPSCs.
- 针对iPSCs分化成髓状细胞系,特别是中性粒细胞.
- 流细胞计分析以评估中性粒细胞发育标志物 (CD15,CD11b,CD16,CD63).
- 评估中性粒细胞功能,包括脱粒和NADPH氧化酶活性.
- 评估巨细胞与中性粒细胞之间的相互作用,包括细胞化.
主要成果:
- 从HPS2 iPSCs中减少CD15阳性细胞的发育.
- HPS2中性粒细胞表现出与循环中的HPS2中性粒细胞相似的特征,包括增加CD63表达和降粒功能受损.
- 在HPS2 iPSC培养的后期阶段,中性粒细胞产量显著下降.
- CD15阴性巨细胞在HPS2培养物中活跃细胞化中性粒细胞,有助于降低中性粒细胞产量.
- 中性粒细胞活力保持正常,表明清除而不是细胞死亡是主要问题.
结论:
- 来自HPS2患者的iPSC为研究HPS2.2中颗粒形成缺陷提供了有价值的模型.
- 在HPS2中,中性粒细胞的发育受到较慢的分化率和巨细胞增加的清除率的阻碍.
- 发育中性粒细胞的巨介导的细胞分裂是导致HPS2中性粒细胞衰竭的关键机制.
- 这个iPSC模型突出显示了有助于HPS2表型的明显细胞缺陷.
相关概念视频
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K